Suppression of hyperalgesia in streptozotocin-induced diabetic mice by a lipopolysaccharide from Pantoea agglomerans

Biol Pharm Bull. 1994 May;17(5):632-4. doi: 10.1248/bpb.17.632.

Abstract

The ability of a lipopolysaccharide from Pantoea agglomerans (LPSp) to relieve hyperalgesia was examined by observing its inhibition of the decrease in the threshold for nociceptive perception, as determined by the tail-pinch test, in streptozotocin-induced diabetic mice. Subcutaneous injection of LPSp suppressed hyperalgesia in streptozotocin-induced diabetic mice and also exerted a therapeutic effect on hyperalgesia in these animals. The present data suggest that LPSp may be effective in relieving the pain associated with diabetic neuropathy.

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / complications*
  • Hyperalgesia / complications
  • Hyperalgesia / drug therapy*
  • Lipopolysaccharides / therapeutic use*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Pain Measurement / drug effects
  • Pain Threshold / drug effects
  • Plants, Medicinal / chemistry*

Substances

  • Lipopolysaccharides